This opportunity is a Request for Information (RFI) for market research on acquiring clinical specimens or synthetic specimen matrices to support diagnostic test development and validation, aligning with national biodefense goals. No submission timeline or budget amount is specified. The government will use responses to refine requirements and develop acquisition strategies, but this RFI does not commit to a solicitation or award. Performance location is not specified. Responses will not be returned and remain with the government.